(Q34592019)

3 August 2017

1 reference

title

Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects (English)

1 reference

3 August 2017

1 reference

Wolfgang Schreibmayer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494009&resulttype=core&format=json

14 May 2020

author name string

Stefan Quasthoff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494009&resulttype=core&format=json

14 May 2020

Claudia Möckel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494009&resulttype=core&format=json

14 May 2020

Walter Zieglgänsberger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494009&resulttype=core&format=json

14 May 2020

language of work or name

1 reference

1 January 2008

1 reference

18482024

CNS Neuroscience & Therapeutics

3 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494009&resulttype=core&format=json

14 May 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494009&resulttype=core&format=json

14 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494009&resulttype=core&format=json

14 May 2020

page(s)

107-119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494009&resulttype=core&format=json

Prophylactic tolperisone for post-exercise muscle soreness causes reduced isometric force--a double-blind randomized crossover control study

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Lidocaine block of cardiac sodium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Sub PPB level determination of eperison in human plasma by GC/MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Identification of Metabolic Pathways Involved in the Biotransformation of Tolperisone by Human Microsomal Enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Rapid and sensitive liquid chromatography-electrospray ionization-mass spectrometry method for the determination of eperisone in human plasma: method and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Silperisone: a centrally acting muscle relaxant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Effects of some centrally acting muscle relaxants on spinal root potentials: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Tolperisone: evaluation of the lidocaine-like activity by molecular modeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Separation of enantiomers on a chiral stationary phase based on ovoglycoprotein. VII. Comparison of chiral recognition ability of ovoglycoprotein from chicken and Japanese quail egg whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

A comparative study of the action of tolperisone on seven different voltage dependent sodium channel isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Mechanisms of action of eperisone on isolated dog saphenous arteries and veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Antinociceptive effects of tizanidine, diazepam and eperisone in isolated spinal cord-tail preparations of newborn rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Effects of Eperisone on Renshaw cells of cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Simultaneous determination of tolperisone and lidocaine by high performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Systemic lidocaine for neuropathic pain relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Separation of basic drug enantiomers by capillary electrophoresis using chicken alpha1-acid glycoprotein: insight into chiral recognition mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Intestinal first-pass metabolism of eperisone in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Suppression of calcium current in a snail neurone by eperisone and its analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Method for recording spinal reflexes in mice: effects of thyrotropin-releasing hormone, DOI, tolperisone and baclofen on monosynaptic spinal reflex potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Mechanisms of depressant action of muscle relaxants on spinal reflexes: participation of membrane stabilizing action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

No blocking effects of the pentapeptide QYNAD on Na+ channel subtypes expressed in Xenopus oocytes or action potential conduction in isolated rat sural nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Molecular determinants of state-dependent block of Na+ channels by local anesthetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Antinociceptive effects of sodium channel-blocking agents on acute pain in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Effects of a new centrally acting muscle relaxant, NK433 (lanperisone hydrochloride) on spinal reflexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Voltage clamping of Xenopus laevis oocytes utilizing agarose-cushion electrodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Use of identical assay conditions for cocaine analog binding and dopamine uptake to identify potential cocaine antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

A randomized, double-blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Effect of muscle relaxants on experimental jaw-muscle pain and jaw-stretch reflexes: a double-blind and placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Some recent high-performance liquid chromatography separations of the enantiomers of pharmaceuticals and other compounds using the Whelk-O 1 chiral stationary phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

Simultaneous micellar LC determination of lidocaine and tolperisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00044.X

[Cavinton and mydocalm in combined therapy of anxiety disorders and tension headaches]

21 January 2018

1 reference

12 December 2020

Chiral resolution of basic drugs by capillary electrophoresis with new glycosaminoglycans

1 reference

12 December 2020

High performance thin layer chromatographic determination of tolperisone hydrochloride

1 reference

12 December 2020

[Treatment of chronic arterial insufficiency of legs with midocalm in elderly]

1 reference

12 December 2020

[Role of midocalm in combined treatment of neuropathic diabetic foot syndrome]

1 reference

12 December 2020

[The use of midokalm in patients with multiple sclerosis]

1 reference

12 December 2020

Mass fragmentographic determination of 1-piperidino-2,4'-dimethylpropiophenone(mydocalm) by use of 1:1 mixture technique

1 reference

12 December 2020

Tolperisone--a novel modulator of ionic currents in myelinated axons.

1 reference

12 December 2020

Reversible Adrenergic α-Receptor Blocking Action Of 2,4’-Dimethyl-3-Piperidino-Propiophenone (Tolperisone)

1 reference

12 December 2020

Spinal pain and its treatment with midocalm

1 reference

12 December 2020

Anaphylactic reactions to tolperisone (Mydocalm)

1 reference

12 December 2020

[Mydocalm, a new drug to relax spastic muscles in neurological diseases.]

1 reference

12 December 2020

Successful use of mydocalm in peripheral arterial disease

1 reference

12 December 2020

Use of Mydocalm in influencing the effect of muscle tremor on the ECG

1 reference

12 December 2020

Mydocalm and muscle tone

1 reference

12 December 2020

Mydocalm causing anaphylaxis

1 reference

12 December 2020

Determination of tolperisone enantiomers in plasma and their disposition in rats

1 reference

12 December 2020

Midocalm in complex therapy of chronic low back pain syndrome

1 reference

12 December 2020

A study of mydocalm efficiency in the treatment of chronic headache of tension

1 reference

12 December 2020

A randomized, double blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke

1 reference

12 December 2020

HPLC determination of tolperisone in human plasma

1 reference

12 December 2020

Gas-liquid chromatographic method for the determination of tolperisone in human plasma: pharmacokinetic and comparative bioavailability studies

1 reference

12 December 2020

[Comparative effciency of bakloferon and tolperizon central muscle relaxants in complex therapy of back pain]

1 reference

12 December 2020

Considerable interindividual variation in the pharmacokinetics of tolperisone HCl

1 reference

12 December 2020

Anti-nicotinic and anti-muscarinic actions of eperisone in the isolated canine atrium

1 reference

12 December 2020

Effects of eperisone-HCl on the stretch reflex in anesthetized cats

1 reference

12 December 2020

Effects of tizanidine, eperisone and afloqualone on feline dorsal horn neuronal responses to peripheral cutaneous noxious and innocuous stimuli

1 reference

12 December 2020

High-dose Mydocalm therapy in certain myogenous headaches.

1 reference

12 December 2020

Study on the effect of 150-mg Mydocalm coated tablets in peripheral vascular diseases and in myotonias of various origin

1 reference

12 December 2020

[Effects of tolperisone hydrochloride on the silent period of the masseter muscle]

1 reference

12 December 2020

Pharmacological studies of the new centrally acting muscle relaxant 4'-ethyl-2-methyl-3-pyrrolidinopropiophenone hydrochloride.

1 reference

12 December 2020

Eperisone, an antispastic agent, possesses vasodilating actions on the guinea-pig basilar artery

1 reference

12 December 2020

[Case of an allergic reaftion to mydocalm]

1 reference

12 December 2020

Treatment of vascular diseases with Mydocalm

1 reference

12 December 2020

The use of mydocalm in the treatment of vascular diseases of the extremities

1 reference

12 December 2020

Determination of tolperisone in pharmaceutical formulations by g. l. c

1 reference

12 December 2020

Pharmacological properties of NK433, a new centrally acting muscle relaxant

1 reference

12 December 2020

State-of-the-art potential clamp device for myelinated nerve fibres using a new versatile input probe

1 reference

12 December 2020

The effects of centrally acting muscle relaxants on the intrathecal noradrenaline-induced facilitation of the flexor reflex mediated by group II afferent fibers in rats

1 reference

12 December 2020

Symptomatic treatment of neurolathyrism with tolperisone HCL (Mydocalm): a randomized double blind and placebo controlled drug trial.

1 reference

12 December 2020

Evaluation of sedative effects of single and repeated doses of 50 mg and 150 mg tolperisone hydrochloride. Results of a prospective, randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

10.1111/J.1527-3458.2008.00044.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494009&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494009&resulttype=core&format=json

14 May 2020

18482024

1 reference